Adage Capital Partners’s Processa Pharmaceuticals PCSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.37M Buy
+3,275,493
New +$7.04M 0.01% 830

Other funds holding PCSA

Adage Capital Partners's PCSA Position: Q3 2026 in Review

Adage Capital Partners opened a new position in Processa Pharmaceuticals (PCSA) in Q3 2026: 3,275,493 shares worth $5.37M. The stake represents 0.01% of the portfolio and ranks #830 among its holdings.

18 funds tracked by Wall St. Rank hold PCSA as of Q3 2026.

  • Adage Capital Partners held 3,275,493 shares of Processa Pharmaceuticals worth $5.37M as of Q3 2026.
  • Processa Pharmaceuticals was a new Adage Capital Partners position in Q3 2026.
  • Processa Pharmaceuticals made up 0.01% of Adage Capital Partners's portfolio in Q3 2026, its #830 holding.
  • 18 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2026.

Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.